Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

1.73
-0.1300-6.99%
Pre-market: 1.750.0200+1.16%05:00 EDT
Volume:7.28M
Turnover:12.91M
Market Cap:596.85M
PE:-2.66
High:1.88
Open:1.85
Low:1.72
Close:1.86
52wk High:4.46
52wk Low:1.04
Shares:345.00M
Float Shares:262.00M
Volume Ratio:1.42
T/O Rate:2.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6510
EPS(LYR):-0.8652
ROE:-42.39%
ROA:-22.08%
PB:1.37
PE(LYR):-2.00

Loading ...

Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]